News HeadLines – 2011

Opening of an additional GMP production facility dedicated to mammalian cell culture.
The French regulatory authority (AFSSAPS) authorized manufacturing operations including the production of biotechnology products, immunology products and extracted products of animal or human origin
Press release

PX'Therapeutics Licenses RIBOVAX's SEBVI Technology for the Development and Manufacturing of Fully Human Monoclonal Antibodies
Press release


We will be attending the following events.
Please do not hesitate to come and see us at:

BioEurope – Milan, Italy – March 14-16th
3rd Annual antibody congress – Beijing, China – March 23-25th
Biovision - Lyon, France - March 27-29th
Vaccine forum 2011 – Barcelona, Spain – May 11-13th
ILSI-Biomed – Tel-Aviv, Israel – May 23-25th
Epic – London, England – June 15th
Bio International Convention – Washington, USA – June 27-30th
BioEurope - Dusseldorf, Germany – October 31st to November 2nd
World Vaccine Congress - Lyon, France - October 10-14th
4ème Rencontres Industriels/Académiques du CLARA - Lyon, France - December 7th